VCNX - Vaccinex GAAP EPS of -$0.11 revenue of $0.05M
- Vaccinex press release ( NASDAQ: VCNX ): Q3 GAAP EPS of -$0.11.
- Revenue of $0.05M (flat Y/Y).
- Cash and cash equivalents and marketable securities on September 30, 2022 were $7.2 million, as compared to $8.6 million as of December 31, 2021.
For further details see:
Vaccinex GAAP EPS of -$0.11, revenue of $0.05M